Are Onyx and Alexion Next? - Presented by: The Aol. On Network

Jim Cramer looks at the implications of the latest biotech deal, Cubist acquiring Trius, and the implications for the biotech sector.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.82 0.23 ▼ 1.35%
PBR $ 13.30 0.89 ▼ 6.27%
F $ 14.59 0.20 ▼ 1.35%
FB $ 76.55 2.49 ▼ 3.15%
SIRI $ 3.42 0.07 ▼ 2.01%
QQQ $ 97.21 1.58 ▼ 1.60%
AAPL $ 99.18 1.57 ▼ 1.56%
CSCO $ 25.03 0.14 ▼ 0.56%

As of 10/1/2014, 04:15 PM
More Most Active